Increased hepatic cholesterol accumulation in transgenic mice overexpressing human secretory phospholipase A2 group IIA.

This publication has 38 references indexed in Scilit:

• Role of Group II Secretory Phospholipase A₂in Atherosclerosis
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1999
• Ultrastructural Localization of Secretory Type II Phospholipase A ₂ in Atherosclerotic and Nonatherosclerotic Regions of Human Arteries
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1998
• A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells
  Immunology Today, 1997
• Expression of secretory group II phospholipase A2 by CD1a positive cells in human atherosclerotic plaques
  Atherosclerosis, 1996
• Alterations in the physicochemical characteristics of low and high density lipoproteins after lipolysis with phospholipase A2. A spin-label study
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
• Secretory group II phospholipase A2 in human atherosclerotic plaques
  Atherosclerosis, 1995
• Changes in epitope exposition of apolipoprotein A-I on the surface of high density lipoproteins after phospholipase A2 treatment
  Atherosclerosis, 1995
• Behaviour of phospholipase-modified HDL towards cultured hepatocytes. I. Enhanced transfers of HDL sterols and apoproteins
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
• Improved Method for Enzymic Determination of Cholesterol in Lipoproteins Separated by Electrophoresis on Thin Layer Agarose Gels
  cclm, 1989
• Mechanism of the hepatic lipase-induced accumulation of high-density lipoprotein cholesterol by cells in culture
  Biochemistry, 1985